281 related articles for article (PubMed ID: 1327769)
1. Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes.
Vandermeers A; Vandenborre S; Hou X; de Neef P; Robberecht P; Vandermeers-Piret MC; Christophe J
Eur J Biochem; 1992 Sep; 208(3):815-9. PubMed ID: 1327769
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist.
Robberecht P; Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers-Piret MC; Vandermeers A; Christophe J
Eur J Biochem; 1992 Jul; 207(1):239-46. PubMed ID: 1321043
[TBL] [Abstract][Full Text] [Related]
3. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
Robberecht P; Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers-Piret MC; Vandermeers A; Christophe J
Mol Pharmacol; 1992 Aug; 42(2):347-55. PubMed ID: 1325033
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for the occupancy of rat brain PACAP receptors and adenylate cyclase activation.
Hou X; Vandermeers A; Gourlet P; Vandermeers-Piret MC; Robberecht P
Neuropharmacology; 1994 Oct; 33(10):1189-95. PubMed ID: 7862254
[TBL] [Abstract][Full Text] [Related]
5. The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK.
Cauvin A; Buscail L; Gourlet P; De Neef P; Gossen D; Arimura A; Miyata A; Coy DH; Robberecht P; Christophe J
Peptides; 1990; 11(4):773-7. PubMed ID: 2172943
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes.
Gourlet P; Woussen-Colle MC; Robberecht P; de Neef P; Cauvin A; Vandermeers-Piret MC; Vandermeers A; Christophe J
Eur J Biochem; 1991 Jan; 195(2):535-41. PubMed ID: 1997328
[TBL] [Abstract][Full Text] [Related]
7. Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J.
Buscail L; Gourlet P; Cauvin A; De Neef P; Gossen D; Arimura A; Miyata A; Coy DH; Robberecht P; Christophe J
FEBS Lett; 1990 Mar; 262(1):77-81. PubMed ID: 2156735
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
Schäfer H; Schwarzhoff R; Creutzfeldt W; Schmidt WE
Eur J Biochem; 1991 Dec; 202(3):951-8. PubMed ID: 1662620
[TBL] [Abstract][Full Text] [Related]
9. [Pituitary adenylate cyclase-activating polypeptide].
Gonzalez BJ; Basille M; Vaudry D; Fournier A; Vaudry H
Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
[TBL] [Abstract][Full Text] [Related]
10. Presence of pituitary adenylate cyclase-activating polypeptide receptors in Y-79 human retinoblastoma cells.
Olianas MC; Ennas MG; Lampis G; Onali P
J Neurochem; 1996 Sep; 67(3):1293-300. PubMed ID: 8752138
[TBL] [Abstract][Full Text] [Related]
11. The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.
Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers A; Vandermeers-Piret MC; Robberecht P; Christophe J
Biochim Biophys Acta; 1991 Jul; 1066(2):245-51. PubMed ID: 1649637
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptor.
Delporte C; Poloczek P; de Neef P; Vertongen P; Ciccarelli E; Svoboda M; Herchuelz A; Winand J; Robberecht P
Mol Cell Endocrinol; 1995 Jan; 107(1):71-6. PubMed ID: 7796937
[TBL] [Abstract][Full Text] [Related]
13. Photoaffinity labeling analysis of the interaction of pituitary adenylate-cyclase-activating polypeptide (PACAP) with the PACAP type I receptor.
Cao YJ; Kojro E; Gimpl G; Jasionowski M; Kasprzykowski F; Lankiewicz L; Fahrenholz F
Eur J Biochem; 1997 Mar; 244(2):400-6. PubMed ID: 9119005
[TBL] [Abstract][Full Text] [Related]
14. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
15. Addition of the (28-38) peptide sequence of PACAP to the VIP sequence modifies peptide selectivity and efficacy.
Gourlet P; Vandermeers A; Vandermeers-Piret MC; De Neef P; Robberecht P
Int J Pept Protein Res; 1996 Oct; 48(4):391-6. PubMed ID: 8919060
[TBL] [Abstract][Full Text] [Related]
16. Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors.
Gourlet P; Vandermeers A; Vandermeers-Piret MC; Rathé J; De Neef P; Robberecht P
Eur J Pharmacol; 1995 Dec; 287(1):7-11. PubMed ID: 8666028
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells.
Moody TW; Zia F; Makheja A
Peptides; 1993; 14(2):241-6. PubMed ID: 8387187
[TBL] [Abstract][Full Text] [Related]
18. Expression of pituitary adenylate cyclase activating polypeptide (PACAP) receptors in human glial cell tumors.
Robberecht P; Woussen-Colle MC; Vertongen P; De Neef P; Hou X; Salmon I; Brotchi J
Peptides; 1994; 15(4):661-5. PubMed ID: 7937342
[TBL] [Abstract][Full Text] [Related]
19. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide.
Somogyvári-Vigh A; Reglodi D
Curr Pharm Des; 2004; 10(23):2861-89. PubMed ID: 15379674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
